With 4 global laboratory locations, Q2 Solutions offers a range of next generation sequencing services to support drug discovery, precision medicine, and clinical development. We offer expertise in assay design, development, and validation, plus a translational genomics team comprised of both assay development and bioinformatic scientists, who lead the industry in high complexity testing and analysis. Q2 Solutions offers the following next generation sequencing services:
Service | Capability |
---|---|
Exome Sequencing |
|
RNA Sequencing | Capabilities include:
|
Whole Genome Sequencing | Optimized method for FFPE and intact material, using low input and minimal amplification |
DNA and RNA Isolations | DNA and RNA extraction capabilities from a large spectrum of original material, including FFPE, blood, tissue, and cells |
HTG Edge Seq Panels |
|
ThermoFisher ion Torrent AmpliSeq and Oncoming Panels |
|
NanoString nCounter Panels |
|
Bioinformatics |
|
In this episode, the second of a three-part series, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage...
Assessing the pharmacokinetics of biologics presents several analytical challenges, from the use of critical reagents and assay sensitivity requirements to regulatory and throughput considerations....
The Thermo Fisher Ion AmpliSeq SARS-CoV-2 Research Panel is a targeted NGS solution that facilitates sequence analysis of the SARS-CoV-2 genome. This assay’s performance and the Pangolin lineage...